All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F21%3A43920842" target="_blank" >RIV/00216208:11120/21:43920842 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/21:N0000217

  • Result on the web

    <a href="https://doi.org/10.1111/bjd.19716" target="_blank" >https://doi.org/10.1111/bjd.19716</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/bjd.19716" target="_blank" >10.1111/bjd.19716</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha

  • Original language description

    Hidradenitis suppurativa (HS) is a relapsing inflammatory skin disease. The cytokines IL-1β, IL-12, IL-23, IL-17 and TNF-α are involved in the inflammatory process. The only approved drug for the treatment of moderate-to-severe cases is adalimumab (TNF-α inhibitor). However, long-term clinical responses range only from 52-57%. Tildrakizumab (anti-IL-23), guselkumab (anti-IL-23) and ustekinumab (anti-IL-12/23) have been successfully used in HS.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30216 - Dermatology and venereal diseases

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    British Journal of Dermatology

  • ISSN

    0007-0963

  • e-ISSN

  • Volume of the periodical

    184

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    2

  • Pages from-to

    966-967

  • UT code for WoS article

    000613406800001

  • EID of the result in the Scopus database

    2-s2.0-85100318942